PHOENIX,
Ariz. , March 2,
2022 /PRNewswire/ -- Creative Medical Technology
Holdings, Inc. ("Creative Medical Technology" or the "Company")
(NASDAQ: CELZ), a leading commercial stage biotechnology company
focused on a regenerative approach to immunotherapy, urology,
neurology, and orthopedics, today announced the appointment of
Sahil Nock as the Company's Chief
Commercial Officer, effective February 28,
2022.
Mr. Nock brings to Creative Medical Technology more than 15
years of healthcare leadership experience in sales, marketing, and
business development. He most recently served as Head of US
Commercial Marketing at Mentor, the worldwide leader in breast
aesthetics and a Johnson & Johnson Medical Device
Company. In this role, he was responsible for growing
Mentor's market leadership position across both augmentation and
reconstruction. Prior to Mentor, he led market development at
Intrexon Corporation, overseeing more than $250 million in deals across a range of
industries from healthcare to agriculture. Prior to that, while at
Abbott he led one of the most successful medical device launches in
history with the introduction of the FreeStyle Libre Diabetes
Continuous Glucose Monitor system. At the start of his career, Mr.
Nock held leadership positions at Danaher and Thermo Fisher
Scientific.
Timothy Warbington, President and
CEO of the Company, commented, "I am excited to welcome Sahil to
work alongside our executive leadership team as we continue to
build a world class organization. Our ability to recruit top talent
is critical to reaching our short and long-term goals. Given
Sahil's proven track record with some of the largest and most
recognized brands in healthcare, and his extensive experience
marketing to healthcare professionals and consumers, I am confident
he will have an immediate impact in accelerating our breakthrough
autologous programs including CaverStem®, FemCelz® and
StemSpine®."
Mr. Nock added, "I was drawn to Creative Medical Technology's
top-notch leadership and disruptive technology platforms. I look
forward to working closely with the team to advance the Company's
regenerative medicine programs, which have the potential to
revolutionize healthcare."
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage
biotechnology company specializing in stem cell technology in the
fields of urology, neurology and orthopedics and trades on Nasdaq
under the ticker symbol CELZ. For further information about the
company, please visit
www.creativemedicaltechnology.com.
Forward Looking Statements
This news release may contain forward-looking statements
including but not limited to comments regarding the timing and
content of upcoming clinical trials and laboratory results,
marketing efforts, funding, etc. Forward-looking statements address
future events and conditions and, therefore, involve inherent risks
and uncertainties. Actual results may differ materially from those
currently anticipated in such statements. See the periodic and
other reports filed by Creative Medical Technology Holdings, Inc.
with the Securities and Exchange Commission and available on the
Commission's website at www.sec.gov.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/creative-medical-technology-appoints-sahil-nock-as-chief-commercial-officer-301493521.html
SOURCE Creative Medical Technology Holdings, Inc.